Skip to main content
. 2016 Sep 23;60(10):6023–6033. doi: 10.1128/AAC.00914-16

TABLE 3.

Activity of hits from validation screens against asexual-stage P. falciparum parasitesa

Cluster Sample identifier cLogPb % growth inhibition at 5 μM EC50c (μM)
P. falciparum 3D7 HeLa cells HEK293 cells IMR90 cells L. amazonensis promastigotes
Cluster 1, aporphines NCGC00162155 1.82 48.38 ± 1.44 4.1 ± 0.18 19.0 ± 6.1 >25 >25 19.4 ± 0.8
NCGC00025349 2.49 47.1 ± 6.28 1.3 ± 0.1 >25 >25 >25 7.32 ± 0.3
NCGC00162160 2.88 17.88 ± 2.67 11.6 ± 1.7 >25 >25 10.7 ± 0.1
Cluster 2, benzazepines NCGC00162096 4.32 51.41 ± 1.44 31 ± 6.4 >25 >25 >25 13.1 ± 0.6
NCGC00015186 4.12 38.03 ± 1.57 >25 24.8 ± 0.1 >25 21.3 ± 3.1
Cluster 4, tetrahydrobenzothiophenes NCGC00098819 5.69 12.64 ± 1.75 5.3 ± 2 15.4 ± 0.9 3.1 ± 1.4 >25
NCGC00098559 5.87 13.2 ± 1.11 4.7 ± 1.4 2.8 ± 0.3 7.2 ± 1.5 >25
NCGC00098561 5.87 27.18 ± 2.19 2.7 ± 1.1 2.7 ± 0.5 5.4 ± 1.2 >25
Singletons NCGC00099116 4.38 10.53 ± 1.84 >25 10.3 ± 1.1 >25 22.2 ± 0.8
NCGC00346707 3.49 80.97 ± 0.63 5.1 ± 0.17 >25 5.2 ± 0.6 >25 6.3 ± 0.04
NCGC00163250 4.13 80.14 ± 1.75 1.7 ± 0.22 >25 10.0 ± 3.4 >25 >25
NCGC00094456 5.38 87.62 ± 0.87 1.9 ± 0.14 12 ± 0.5 7.3 ± 1.0 17.6 ± 3.6 2.3 ± 0.1
NCGC00162149 −0.58 29.69 ± 2.31 >25 >25 >25 16.4 ± 3.5
NCGC00250410 5.67 91.12 ± 0.33 0.78 ± 0.04 12.8 ± 4.2 >25 >25 20.1 ± 5
NCGC00262398 5.02 23.42 ± 1.13 10.1 ± 0.2 8.5 ± 1.7 23.6 ± 1.5 21.5 ± 2.7
NCGC00018296 6.73 52.19 ± 2.48 5.0 ± 0.41 >25 >25 >25 3.5 ± 0.7
NCGC00242503 5.52 15.01 ± 5.17 >25 24.3 ± 1.0 >25 12.1 ± 0.3
NCGC00016069 1.49 11.47 ± 3.49 >25 >25 >25 >25
a

Only compounds that inhibited P. falciparum growth by more than 10% at 5 μM are included.

b

cLogP values were calculated using ChemBridge software.

c

P. falciparum dose-response curves for compounds that caused >45% growth inhibition at 10 μM were performed in duplicate, and averages were used to resolve EC50s. All human cell lines were evaluated in three independent experiments.